Ads
related to: immunology
Search results
Jasper Therapeutics targets asthma in new Phase 1b/2a study By Investing.com
Investing.com· 1 day agoThis study aims to explore the drug's potential to deplete mast cells, which are known to play a key...
Difficulty swallowing? You may have eosinophilic esophagitis
Homenewshere.com· 2 days agoDoes food feel like it gets stuck in your throat when you eat? It involves inflammation and swelling...
Experts Reveal The Foods And Drinks That Cause Congestion, And Now I Think It's About Time I Changed...
BuzzFeed via Yahoo News· 4 days agoJyothi Tirumalasetty, a clinical assistant professor specializing in allergy and immunology at...
Study Offers Clues on Asthma Control for Patients With Concurrent Diabetes
MedPage Today· 5 days agoHowever, patients taking SGLT2 inhibitors had similar incidences of asthma exacerbations that required use of systemic corticosteroids compared with metformin (17.3 vs 18.1 per 100 person-years ...
Bulletin from Sobi's Annual General Meeting (AGM)
FOX 59 Indianapolis· 12 hours agoThe Swedish Orphan Biovitrum AB (publ) (SobiĀ®) AGM was convened today on 14 May 2024. The AGM adopted the income statements and the balance sheets and...
Attovia secures $105m to advance development of lead programmes
Pharmaceutical Technology via Yahoo Finance· 5 days agoThrough initial clinical data readouts, Attovia will channel the funding proceeds towards advancing...
Nektar Therapeutics Reports First Quarter 2024 Financial Results
The Mammoth Times· 5 days agoCash and investments in marketable securities at March 31, 2024 were $326.0 million as compared to $329.4 million at December 31, 2023. Nektar's cash and marketable securities are expected to ...
Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoNektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics...
Large Cap Trio for Value, Growth and Yield
MoneyShow via Yahoo Finance· 2 days agoWith a solid economy and a Fed still likely to cut interest rates this year, we believe the dividend yield of 2.6% and forward P/E ratio of 14 on our portfolio holdings are attractive, especially ...
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Motley Fool via Yahoo Finance· 4 days agoEli Lilly is a far more diversified company than Novo Nordisk. The company's products span...